CCL(CCL)
CCL
Q3 2026 EPS Estimate
$1.36
Sep 28, 2026 · Reports before open
Revenue Estimate
$8.40B
FY2026E EPS$2.24
FY2027E EPS$2.64
Analyst Sentiment
Wall St. Consensus
Buy23 analysts·High coverage
71
Score
19 Buy (83%)4 Hold (17%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1983%
Hold
417%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$30.00
+5.2%
Consensus
$36.00
+26.3%
Bull
$42.00
+47.3%
12-Month Target Range23 analysts
$30.00$36.00$42.00
Current $28.51Consensus
Current Price
$28.51
Upside to Consensus
$7.49
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+3.53%
EPS+17.91%
FY2028
Rev+4.34%
EPS+16.67%
FY2029
Rev+4.05%
EPS+13.04%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $27.62B | $28.60B | $29.84B | $31.05B | $32.14B |
| Low | $27.44B | $28.11B | $29.76B | $30.64B | $31.72B |
| High | $27.88B | $28.96B | $29.92B | $31.48B | $32.59B |
| EBITDA Avg | $-2.59B | $-2.68B | $-2.80B | $-2.91B | $-3.02B |
| Low | $-2.62B | $-2.72B | $-2.81B | $-2.96B | $-3.06B |
| High | $-2.58B | $-2.64B | $-2.79B | $-2.88B | $-2.98B |
| EBIT Avg | $-5.38B | $-5.57B | $-5.81B | $-6.04B | $-6.26B |
| Low | $-5.43B | $-5.64B | $-5.82B | $-6.13B | $-6.34B |
| High | $-5.34B | $-5.47B | $-5.79B | $-5.96B | $-6.17B |
| Net Income Avg | $3.03B | $3.69B | $4.31B | $4.88B | $5.23B |
| Low | $2.93B | $3.59B | $4.10B | $4.80B | $5.14B |
| High | $3.21B | $3.80B | $4.53B | $4.97B | $5.33B |
| EPS Avg | $2.24 | $2.64 | $3.08 | $3.48 | $3.73 |
| Low | $2.09 | $2.56 | $2.92 | $3.42 | $3.67 |
| High | $2.29 | $2.71 | $3.23 | $3.55 | $3.80 |
| Analysts (Rev / EPS) | 19 / 14 | 19 / 17 | 14 / 9 | 7 / 7 | 9 / 3 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $8.40B | $6.44B | $6.31B | $6.89B | $8.72B | $6.70B | $6.56B | $7.19B |
| Low | $8.31B | $6.41B | $6.24B | $6.81B | $8.63B | $6.62B | $6.49B | $7.11B |
| High | $8.48B | $6.48B | $6.42B | $7.01B | $8.88B | $6.81B | $6.68B | $7.31B |
| EBITDA Avg | $-789M | $-604M | $-592M | $-647M | $-819M | $-629M | $-616M | $-675M |
| Low | $-796M | $-608M | $-603M | $-658M | $-834M | $-640M | $-627M | $-687M |
| High | $-780M | $-602M | $-586M | $-640M | $-810M | $-622M | $-609M | $-667M |
| EBIT Avg | $-1.63B | $-1.25B | $-1.23B | $-1.34B | $-1.70B | $-1.30B | $-1.28B | $-1.40B |
| Low | $-1.65B | $-1.26B | $-1.25B | $-1.36B | $-1.73B | $-1.33B | $-1.30B | $-1.42B |
| High | $-1.62B | $-1.25B | $-1.21B | $-1.33B | $-1.68B | $-1.29B | $-1.26B | $-1.38B |
| Net Income Avg | $1.88B | $383M | $273M | $698M | $2.13B | $501M | $333M | $805M |
| Low | $1.85B | $356M | $269M | $688M | $2.10B | $494M | $328M | $794M |
| High | $1.91B | $397M | $279M | $714M | $2.18B | $512M | $341M | $824M |
| EPS Avg | $1.35 | $0.28 | $0.20 | $0.50 | $1.54 | $0.36 | $0.24 | $0.58 |
| Low | $1.33 | $0.26 | $0.19 | $0.50 | $1.52 | $0.36 | $0.24 | $0.57 |
| High | $1.37 | $0.29 | $0.20 | $0.51 | $1.57 | $0.37 | $0.25 | $0.59 |
| Analysts (Rev / EPS) | 14 / 13 | 13 / 13 | 6 / 5 | 7 / 6 | 8 / 7 | 8 / 7 | 6 / 7 | 9 / 10 |